Roche turns to app in fight against Multiple Sclerosis

The Swiss drugmaker is trying to get 10,000 patients to start using its Floodlight app in an ambitious attempt to better understand MS — but also to get patients to give companies a front seat to intimate details of their day-to-day lives.